R&D/Clinical Trials

Latest News

Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor
Sage and Biogen Halt Phase II Study After Novel Drug Shows No Significant Improvement in Treating Essential Tremor

July 24th 2024

Moving forward, Sage Therapeutics and Biogen intend to cease further clinical development of SAGE-324 for essential tremor.

Phase III Trial Data Demonstrates Efficacy of Lenacapavir in Preventing HIV in Cisgender Women
Phase III Trial Data Demonstrates Efficacy of Lenacapavir in Preventing HIV in Cisgender Women

July 24th 2024

Vivacelle Bio Launches Phase III Clinical Trial for VBI-S to Treat Hypovolemic Septic Shock
Vivacelle Bio Launches Phase III Clinical Trial for VBI-S to Treat Hypovolemic Septic Shock

July 23rd 2024

CT-996 Demonstrates Significant Weight Loss in Patients with Obesity and Type 2 Diabetes
CT-996 Demonstrates Significant Weight Loss in Patients with Obesity and Type 2 Diabetes

July 18th 2024

Amy Ripston
Driving Sample Excellence: Q&A with Amy Ripston

July 17th 2024

More News